Vericel Corp. | |
Stock Exchange | NASDAQ Stock Market |
EPS |
$0.1 |
Market Cap |
$832.55 M |
Shares Outstanding |
43.91 M |
Public Float |
43.44 M |
Address |
64 Sidney Street Cambridge Massachusetts 02139 United States |
Employees | - |
Website | http://www.vcel.com |
Updated | 07/08/2019 |
Vericel Corp. engages in the research, product development, manufacture, and distribution of patient-specific, expanded cellular therapies to repair and regenerate damaged tissues and organs to normal structure and function. Its product portfolio include MACI and Epicel. The MACI portfolio is FDA-approved product that applies the process of tissue engineering to grow cells on scaffolds using healthy cartilage tissue from the patient's own knee. |